RD
Robert Driscoll Wedbush Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Replimune Group
REPL
$454M
| $5.81 | $4 |
31%
downside
| Neutral | 1 month ago |
|
2
Kura Oncology
KURA
$706M
| $8.13 | $36 |
343%
upside
| Outperform | 2 months ago |
|
3
Revolution Medicines
RVMD
$7.28B
| $38.95 | $67 |
72%
upside
| Outperform | 4 months ago |
|
4
Monte Rosa Therapeutics
GLUE
$303M
| $4.91 | $17 |
246%
upside
| Outperform | 5 months ago |
|
5
Arvinas
ARVN
$559M
| $7.61 | $12 |
58%
upside
| Neutral | 5 months ago |
|
6
Day One Biopharmaceuticals
DAWN
$759M
| $7.41 | $32 |
332%
upside
| Outperform | 6 months ago |
|
7
IDEAYA Biosciences
IDYA
$2.26B
| $25.83 | $52 |
101%
upside
| Outperform | 8 months ago |
|
8
Tyra Biosciences
TYRA
$647M
| $12.14 | $28 |
131%
upside
| Outperform | 10 months ago |
|
9
Arcus Biosciences
RCUS
$1.23B
| $11.56 | $30 |
160%
upside
| Outperform | 11 months ago |
|
10
Cullinan Oncology
CGEM
$408M
| $6.91 | $36 |
421%
upside
| Outperform | 11 months ago |
|
11
Foghorn Therapeutics
FHTX
$305M
| $5.39 | $13 |
141%
upside
| Outperform | 1 year ago |
|
12
Tango Therapeutics
TNGX
$760M
| $6.83 | $13 |
90%
upside
| Outperform | 1 year ago |
|
13
Janux Therapeutics
JANX
$1.44B
| $23.94 | $74 |
209%
upside
| Outperform | 1 year ago |
|
14
Compass Therapeutics
CMPX
$466M
| $3.37 | $8 |
137%
upside
| Outperform | 1 year ago |
|
15
Geron
GERN
$880M
| $1.38 | $7 |
407%
upside
| Outperform | 1 year ago |
|
16
CytomX Therapeutics
CTMX
$346M
| $2.10 | $8 |
281%
upside
| Outperform | 1 year ago |
|
17
Arbutus Biopharma
ABUS
$769M
| $4.01 | $4 |
0%
downside
| Outperform | 5 years ago |
|